Carrot expands fertility care with Oura and Dexcom wearable data
Carrot expands fertility care with Oura and Dexcom wearable data | MobiHealthNews
Skip to main content…
Continue ReadingCarrot expands fertility care with Oura and Dexcom wearable data | MobiHealthNews
Skip to main content…
Continue ReadingWhat You Should Know:
– Carrot, a global fertility and family care platform announced a significant strategic partnership with ŌURA, the smart ring company, and Dexcom, the global leader in glucose biosensing. The collaboration introduces…
Continue ReadingWhat You Should Know:
– FriskaAi, an AI-powered healthcare platform, has announced an agreement with Dexcom, Inc., a global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring…
Continue ReadingGoogle said at a healthcare artificial intelligence roundtable it hosted Thursday that Agentspace is its fastest-growing artificial intelligence product. Launched earlier this year, the platform and its companion Vertex AI Model Garden allow enterprises to create agents…
Continue ReadingGlucose monitoring specialist Dexcom is expanding its partnership with health-tracking ring maker Oura to provide Stelo users and ring wearers with metabolic health features, including meal insights and glucose data. Stelo provides individuals 18 and…
Continue ReadingWhat You Should Know:
– ŌURA, the creator of the leading smart ring, today announced a significant expansion of its health tracking capabilities with the introduction of two new AI-driven metabolic health features: Meals and…
Continue ReadingExtended Wear CGM Innovation Redefines Diabetes Management
Dexcom has reached a significant milestone with FDA clearance for its G7 15-Day continuous glucose monitoring system for adults 18 and older. This next-generation device extends wear time…
Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational diabetes. G7 15 Day,…
Continue ReadingWhat You Should Know:
– Dexcom, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for individuals over the age of 18…
Continue ReadingCardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with glucose monitoring specialist Dexcom to integrate glucose data from the Dexcom G7 into its SimpleSense nanotechnology-enabled wearable. Nanowear offers home-based, AI-enabled digital diagnostics…
Continue Reading